Symbol
|
RMAFCV | RMAFFV | RMBGYV | RMBKMV | RMAHIV | OTSRCH | RMAV6V | OYFRCH | OVLRCH | RMA4KV | AAYMTQ | Z0A42Z | RMA9EV | RMALYV | RMBPAV | RMAZ0V | RMBJ8V | RMASDV | RMBQSV | ABKBTQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Name | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible |
Underlying
|
Compagnie Financière Richemont SA / Galderma Group AG / Hermès International S.A. / LVMH Moet Hennessy Louis Vuitton | Alcon / Galderma Group AG / Sandoz Group AG | Alcon / Galderma Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Nestlé S.A. / Novartis AG / Roche AG | Estée Lauder Co. Inc. / Galderma Group AG / L'Oréal S.A. / Unilever N.V. | Bachem Hldg. AG / Galderma Group AG / Sandoz Group AG | Compagnie Financière Richemont SA / Galderma Group AG / Givaudan | DOCMORRIS AG / Galderma Group AG | Galderma Group AG / Roche AG / Straumann Hldg. AG | Galderma Group AG / Galenica AG / Tecan Group AG | Bachem Hldg. AG / Galderma Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Sandoz Group AG | Douglas Hldg. AG / Galderma Group AG / Unilever N.V. | Compagnie Financière Richemont SA / Galderma Group AG / Swatch Group I | CREDIT SUISSE UBS MERGER / Galderma Group AG / Sonova Hldg. AG | CREDIT SUISSE UBS MERGER / Ems-Chemie Hldg. AG / Galderma Group AG / Novartis AG | CREDIT SUISSE UBS MERGER / Galderma Group AG / Tecan Group AG | Galderma Group AG / Givaudan / Ypsomed Hldg. AG | CREDIT SUISSE UBS MERGER / DOCMORRIS AG / Galderma Group AG | Alcon / Galderma Group AG / Novartis AG / Sandoz Group AG |
Issuer
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Date of maturity
|
20.10.2025 | 29.06.2026 | 02.02.2026 | 16.02.2026 | 24.02.2026 | 02.03.2026 | 20.03.2026 | 30.09.2025 | 13.03.2026 | 07.04.2026 | 20.03.2026 | 09.10.2025 | 28.09.2026 | 19.10.2026 | 27.04.2026 | 12.10.2026 | 05.05.2026 | 11.05.2026 | 18.05.2026 | 12.11.2026 |
Bid | 72.90 | 99.40 | 96.90 | 99.80 | 70.90 | 68.60 | - | 74.51 | 94.91 | 63.40 | 74.95 | - | 64.40 | 86.60 | 69.30 | 71.20 | 68.10 | 95.90 | 69.90 | 96.52 |
Ask | - | 100.40 | 99.50 | 100.80 | - | - | - | - | 95.71 | - | - | - | - | 88.20 | - | - | - | 99.00 | - | 97.32 |